Quality of Data through comprehensive clinical Data Management
1. Study setup
Input in CRF design
Creation of annotated CRF
Data Management Plan (DMP)
Data Cleaning Plan (DCP) & Programming
2. Study conduct
E-Platform and database hosting
Handling reference ranges
Data Cleaning Process
(Risk-based) Data Monitoring
3. Study close out
Data reconciliation across multiple sources and systems
Database lock, transfer & archiving
Data Management Report
As a CDISC expert, Telemedicine Technologies offers high quality Data Management services.
CDISC creates clarity in clinical research by bringing together a global community of experts to develop and advance data standards of the highest quality. CDISC enables the accessibility, interoperability and reusability of data for more meaningful research that has greater impact on global health. Based on the development of its own data collection and clinical data management tools, Telemedicine Technologies has seamlessly built processes to apply CDASH and ODM* standards during eCRF & database design and export.
Based on ODM standards, Telemedicine Technologies has built cutting-edge tools that allow for compliance with SDTM* standard.
Based on ODM data collected in the eCRF, Telemedicine Technologies provides SDTM mapping which will then be transferred to biostatistics for further analysis resulting in ADaM datasets. The SDTM datasets generated by Telemedicine Technologies are provided together with a SDTM Mapping Guide (which defines the mapping between collected data and CDISC domains), a SDTM Annotated CRF and a define.xml which describes the metadata of the SDTM package.
* ODM (Operational Data Model) is a recognised Operational Data Model for data collection, exchange and archiving. Based on ODM standards Telemedicine Technologies has built cutting-edge tools that allow for compliance with SDTM* (Study Data Tabulation Model) standard.
* SDTM (Study Data Tabulation Model) provides a standard for organising and formatting data to streamline processes in collection, management, analysis and reporting. SDTM is one of the required standards for data submission to FDA (U.S.) and PMDA (Japan). Based on ODM data collected in the eCRF, Telemedicine Technologies provides SDTM mapping.
Telemedicine Technologies has been processing electronic data for the clinical research industry for over 2 decades. Telemedicine Technologies Standard Operating Procedures (SOPs) and software are built to address and ensure the confidentiality, integrity and availability of data and systems. Telemedicine Technologies software and related e-Platforms comply with GAMP-5 guidelines, FDA 21 CFR Part 11 recommendations, ICG E6 (R2). All communications and data are encrypted. Study documents are stored in secured and password-protected systems. Systems and data are backed up on a daily basis and policies are in place for retention and to ensure integrity and security of the backups.
Telemedicine Technologies fully complies with the EU General Data Protection Regulation 2016/679 of 25th May 2018 and certifies that all procedures are in place to guarantee ad hoc processing of all personal data.
Download our Flyer ON STATE-OF-THE-ART DATA SERVICES
Telemedicine Technologies continues to acquire companies that provide innovative solutions and services to its customers. The acquisition of the CTMA (Clinical Trials Mobile Application) software suite enables Telemedicine Technologies to offer investigating centres assistance to accelerate patient recruitment in clinical trials, and to ensure their commitments to sponsors. The digital transformation of healthcare institutions is […]
Fierce Biotech Trialbee, a patient enrollment company, inked a partnership deal with Acclinate in a push to accelerate wider patient diversity in clinical trials. Under the partnership, Sweden-based Trialbee will get access to Acclinate’s NOWINCLUDED offering that engages diverse populations on health-related issues, the company said in a Dec. 13 press release. Founded in 2020, Birmingham, Alabama-based […]
Applied Clinical Trials The concept of decentralized clinical trials (DCT) is still in its infancy in the industry, although the pandemic has facilitated its adoption. FDA has issued a guidance document for operating under the pandemic, as did EMA which outline several characteristics of DCTs, including remote study visits, clinical outcomes assessments (COAs), monitoring and inspections, to name […]